Literature DB >> 8905432

Occupational exposure during nitric oxide inhalational therapy in a pediatric intensive care setting.

D G Markhorst1, T Leenhoven, J W Uiterwijk, J Meulenbelt, A J van Vught.   

Abstract

OBJECTIVE: To determine the amount of occupational exposure to nitric oxide (NO) and nitrogen dioxide (NO2) during NO inhalational therapy.
DESIGN: In a standard pediatric intensive care room, 800 ppm NO was delivered to a high-frequency oscillator and mixed with 100% O2 to obtain 20 ppm NO in the inspiratory gas flow. NO and NO2 concentrations in room air were measured using a chemiluminescence analyzer. Air samples were taken from a height of 150 cm at a horizontal distance of 65 cm from the ventilator in a nonventilated and in a well-ventilated room with and without an expiratory gas exhaust under normal intensive care environmental conditions.
SETTING: Pediatric intensive care unit in a university children's hospital. MEASUREMENTS AND
RESULTS: Maximal concentrations of NO and NO2 were reached after 4 h NO use. Without exhaust, in a nonventilated room, environmental NO and NO2 concentration rose to a maximum of 0.462 and 0.064 ppm, respectively. With the use of an expiratory gas exhaust, NO and NO2 concentrations were 0.176 and 0.042 ppm, respectively. With normal air-conditioning, these values were 0.075 and 0.034 ppm, respectively, without the use of an expiratory gas exhaust. With expiratory gas exhaust added to normal air-conditioning, values for NO and NO2 were 0.035 and 0.030 ppm, respectively.
CONCLUSIONS: The use of 20 ppm NO, even under minimal room ventilation conditions, did not lead to room air levels of NO or NO2 that should be considered toxic to adjacent intensive care patients or staff. Slight increases in NO and NO2 concentrations were measurable but remained within occupational safety limits. The use of an exhaust system and normal room ventilation lowers NO and NO2 concentrations further to almost background levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905432     DOI: 10.1007/bf02044122

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

Review 1.  Health effects and sources of indoor air pollution. Part I.

Authors:  J M Samet; M C Marbury; J D Spengler
Journal:  Am Rev Respir Dis       Date:  1987-12

2.  Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn.

Authors:  J P Kinsella; S H Abman
Journal:  Pediatrics       Date:  1993-05       Impact factor: 7.124

3.  Bleeding time prolongation and NO inhalation.

Authors:  M Högman; C Frostell; H Arnberg; G Hedenstierna
Journal:  Lancet       Date:  1993-06-26       Impact factor: 79.321

4.  Controlled exposure of volunteers with chronic obstructive pulmonary disease to nitrogen dioxide.

Authors:  W S Linn; D A Shamoo; C E Spier; L M Valencia; U T Anzar; T G Venet; E L Avol; J D Hackney
Journal:  Arch Environ Health       Date:  1985 Nov-Dec

5.  Alternatives to ECMO.

Authors:  S M Donn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-03       Impact factor: 5.747

6.  DNA deaminating ability and genotoxicity of nitric oxide and its progenitors.

Authors:  D A Wink; K S Kasprzak; C M Maragos; R K Elespuru; M Misra; T M Dunams; T A Cebula; W H Koch; A W Andrews; J S Allen
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

7.  Airway responses to 2.0 ppm nitrogen dioxide in normal subjects.

Authors:  V Mohsenin
Journal:  Arch Environ Health       Date:  1988 May-Jun

Review 8.  Health effects of air pollution. A review of clinical studies.

Authors:  H Gong
Journal:  Clin Chest Med       Date:  1992-06       Impact factor: 2.878

9.  Guidelines for the safe administration of inhaled nitric oxide.

Authors:  O I Miller; D S Celermajer; J E Deanfield; D J Macrae
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

10.  Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations.

Authors:  M Moutafis; Z Hatahet; M H Castelain; M H Renaudin; A Monnot; M Fischler
Journal:  Intensive Care Med       Date:  1995-06       Impact factor: 17.440

View more
  5 in total

1.  Workplace NO and NO2 during combined treatment of infants with nasal CPAP and NO.

Authors:  Robert Lindwall; Mats E Svensson; Claes G Frostell; Staffan Eksborg; Lars E Gustafsson
Journal:  Intensive Care Med       Date:  2006-10-17       Impact factor: 17.440

2.  A comparison of vascular effects from complex and individual air pollutants indicates a role for monoxide gases and volatile hydrocarbons.

Authors:  Matthew J Campen; Amie K Lund; Melanie L Doyle-Eisele; Jacob D McDonald; Travis L Knuckles; Annette C Rohr; Eladio M Knipping; Joe L Mauderly
Journal:  Environ Health Perspect       Date:  2010-03-02       Impact factor: 9.031

3.  Successful treatment of chronic thromboembolic pulmonary hypertension with inhaled nitric oxide after right ventricular thrombectomy.

Authors:  Kiyoaki Takaba; Masaki Aota; Michihito Nonaka; Akihiro Sugimoto; Yutaka Konishi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-05

4.  Non-invasive inhaled nitric oxide in the treatment of hypoxemic respiratory failure in term and preterm infants.

Authors:  R Sahni; X Ameer; K Ohira-Kist; J-T Wung
Journal:  J Perinatol       Date:  2016-10-06       Impact factor: 2.521

5.  Inhaled nitric oxide applications in paediatric practice.

Authors:  A Bernasconi; M Beghetti
Journal:  Images Paediatr Cardiol       Date:  2002-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.